Rebeca Sanz Barriuso
My overarching mission is to leverage my healthcare, life sciences, and wellness expertise to enhance people's lives while driving digital transformation in the health sector. And my true measure of success lies in the positive impact I have on people's lives. Besides this, with nearly 20 years of international experience in healthcare and life sciences, my strength lies in crafting growth strategies for innovative firms, bridging the gap between cutting-edge innovations and market realities, and cultivating trust-based relationships among key stakeholders. I've held pivotal roles as the Chief Commercial Officer at Sincrolab, a prescription-based Digital Therapeutic (DTx) startup, and as the VP of Growth and Commercial Strategy at DFnet, a SaaS B2B tech company offering cloud-based solutions and consulting services in clinical trials. My responsibilities included shaping various global departments' strategic direction, performance, and alignment. I've led the executive committees of both organizations and collaborated with global cross-functional teams to design and execute effective commercial strategies, actively contributing to innovation processes. Furthermore, I supervised the development and execution of brand positioning, messaging, and communication strategies. I've also been instrumental in analyzing and optimizing KPIs. Some notable and recent achievements in my career include: - Established a global high-performing team comprising strategy, business development, and marketing professionals - Lead change management efforts, implementing OKRs and EOS Traction models across the entire organization - Successfully formulated a 5-year strategic plan, leading to a 15% increase in operational efficiency and profitability - Secured a major pharmaceutical contract and launched +10 health tech product lines in the US market - Undertaken a global market repositioning of a portfolio consisting of 5 tech innovations - Led a transformation from a -17% to +5% year-on-year top-line revenue amidst the challenges of COVID-19 - Created the first holistic oncology consultancy, reducing patient readmissions by 20% - Established the first specialized Oncology Clinical Trials Unit for ENT and breast cancer. I've also made significant contributions in publications, garnered multiple awards, and hold an Executive MBA from IESE Business School, a PharmD, a Registered Dietician credential, and a Disruptive Strategy and Innovation certificate from Harvard Business School. Currently, I am in the final stages of completing an MSc in Behavioral Sciences and Neuroscience.